Schott Pharma, a pioneer in drug containment and delivery solutions, invested over 100 million euros in its existing site in Lukácsháza, Hungary, to expand its capacity for sterile ready-to-use (RTU) cartridges. The move aligns with the company’s expansion strategy to increase its share of these high-margin products.  Following the opening of a new facility for prefillable glass syringes at the site in 2024, the company has now broken ground for another facility that will add further man...